PRESS RELEASES

Featured post

February 01, 2023

Exact Sciences and PGA Tour Champions Extend Partnership Through 2027

Exact Sciences and PGA Tour Champions Extend Partnership Through 2027

Read more »

Featured post

January 08, 2023

Exact Sciences Announces Preliminary Fourth Quarter 2022 Results

Exact Sciences Announces Preliminary Fourth Quarter 2022 Results

Read more »

Featured post

January 07, 2023

Medicare and Insurance Policy Updates in 2023 Will Improve Cancer Screening Access by Removing Patient Colonoscopy Cost Following a Positive Cologuard® Test

Medicare and Insurance Policy Updates in 2023 Will Improve Cancer Screening Access by Removing Patient Colonoscopy Cost

Read more »

February 01, 2023

Exact Sciences and PGA Tour Champions Extend Partnership Through 2027
January 08, 2023

Exact Sciences Announces Preliminary Fourth Quarter 2022 Results
January 07, 2023

Medicare and Insurance Policy Updates in 2023 Will Improve Cancer Screening Access by Removing Patient Colonoscopy Cost Following a Positive Cologuard® Test
December 09, 2022

Exact Sciences Presents First Time Data Detailing Ability to Predict Radiation Therapy Benefit in Breast Cancer Patients
December 06, 2022

Exact Sciences Highlights the Impact of Precision Oncology Portfolio on Breast Cancer Treatment with 10 New Data Presentations at SABCS^® 2022
November 03, 2022

Exact Sciences Announces Third Quarter 2022 Results Reports Record Revenue, Raises Full-Year Guidance, Accelerates Path to Profitability
October 24, 2022

Exact Sciences Expands Leadership in Colorectal Cancer Screening with New Data Presented at the American College of Gastroenterology 2022 Annual Meeting
September 22, 2022

Exact Sciences Awards Grants to Federally Qualified Health Centers Focused on Improving Colorectal Cancer Screening of Vulnerable Populations
September 10, 2022

Exact Sciences Demonstrates Power of Multi-Cancer Early Detection Approach with Data Presentation at the 2022 European Society for Medical Oncology Congress
August 02, 2022

Exact Sciences Announces Second Quarter 2022 Results
August 02, 2022

Exact Sciences and West German Study Group Announce New Study to Validate Detection of Minimal Residual Disease in Early-Stage Breast Cancer Patients
July 08, 2022

Exact Sciences Applauds Proposed CMS Change to Colorectal Cancer Screening Policy

Choose your country or region:

PRESS RELEASES

Exact Sciences and PGA Tour Champions Extend Partnership Through 2027

Exact Sciences Announces Preliminary Fourth Quarter 2022 Results

Medicare and Insurance Policy Updates in 2023 Will Improve Cancer Screening Access by Removing Patient Colonoscopy Cost Following a Positive Cologuard® Test

Exact Sciences and PGA Tour Champions Extend Partnership Through 2027

Exact Sciences Announces Preliminary Fourth Quarter 2022 Results

Medicare and Insurance Policy Updates in 2023 Will Improve Cancer Screening Access by Removing Patient Colonoscopy Cost Following a Positive Cologuard® Test

Exact Sciences Presents First Time Data Detailing Ability to Predict Radiation Therapy Benefit in Breast Cancer Patients

Exact Sciences Highlights the Impact of Precision Oncology Portfolio on Breast Cancer Treatment with 10 New Data Presentations at SABCS^® 2022

Exact Sciences Announces Third Quarter 2022 Results Reports Record Revenue, Raises Full-Year Guidance, Accelerates Path to Profitability

Exact Sciences Expands Leadership in Colorectal Cancer Screening with New Data Presented at the American College of Gastroenterology 2022 Annual Meeting

Exact Sciences Awards Grants to Federally Qualified Health Centers Focused on Improving Colorectal Cancer Screening of Vulnerable Populations

Exact Sciences Demonstrates Power of Multi-Cancer Early Detection Approach with Data Presentation at the 2022 European Society for Medical Oncology Congress

Exact Sciences Announces Second Quarter 2022 Results

Exact Sciences and West German Study Group Announce New Study to Validate Detection of Minimal Residual Disease in Early-Stage Breast Cancer Patients

Exact Sciences Applauds Proposed CMS Change to Colorectal Cancer Screening Policy

Multimedia

Quick Links

Choose your country or region:

PRESS RELEASES

Exact Sciences and PGA Tour Champions Extend Partnership Through 2027

Exact Sciences Announces Preliminary Fourth Quarter 2022 Results

Medicare and Insurance Policy Updates in 2023 Will Improve Cancer Screening Access by Removing Patient Colonoscopy Cost Following a Positive Cologuard® Test

Exact Sciences and PGA Tour Champions Extend Partnership Through 2027

Exact Sciences Announces Preliminary Fourth Quarter 2022 Results

Medicare and Insurance Policy Updates in 2023 Will Improve Cancer Screening Access by Removing Patient Colonoscopy Cost Following a Positive Cologuard® Test

Exact Sciences Presents First Time Data Detailing Ability to Predict Radiation Therapy Benefit in Breast Cancer Patients

Exact Sciences Highlights the Impact of Precision Oncology Portfolio on Breast Cancer Treatment with 10 New Data Presentations at SABCS® 2022

Exact Sciences Announces Third Quarter 2022 Results Reports Record Revenue, Raises Full-Year Guidance, Accelerates Path to Profitability

Exact Sciences Expands Leadership in Colorectal Cancer Screening with New Data Presented at the American College of Gastroenterology 2022 Annual Meeting

Exact Sciences Awards Grants to Federally Qualified Health Centers Focused on Improving Colorectal Cancer Screening of Vulnerable Populations

Exact Sciences Demonstrates Power of Multi-Cancer Early Detection Approach with Data Presentation at the 2022 European Society for Medical Oncology Congress

Exact Sciences Announces Second Quarter 2022 Results

Exact Sciences and West German Study Group Announce New Study to Validate Detection of Minimal Residual Disease in Early-Stage Breast Cancer Patients

Exact Sciences Applauds Proposed CMS Change to Colorectal Cancer Screening Policy

Multimedia

Quick Links

Follow us on

Exact Sciences Highlights the Impact of Precision Oncology Portfolio on Breast Cancer Treatment with 10 New Data Presentations at SABCS^® 2022